3rd Annual Next Generation Sequencing Congress
November 14, 2011 at 8:00 AM - November 15, 2011 at 5:00 PM
Radisson Edwardian, London, London
Over two days, the 3rd Annual Next Generation Sequencing Congress will attract over 250 experts from both academia and pharma senior practitioners, working in all aspects of next generation sequencing including analytical genomics, computational biology, oncology, RNA profiling, molecular genomics, microbiology, nutrition, biomarkers, bioinformatics, data management and clinical & diagnostics development from Europe and America. This prestigious event provides a forum for practitioners and researchers to learn more about key solutions being provided to their industry, analysis of current technologies and their applications, network with their peers and address key industry concerns through a series of cutting edge conference presentations and interactive exhibition room in a professional yet relaxed environment.
Event Owner: Ross McIvor (Marketing Manager at Oxford Global Conferences)

Updates

Kip Bodi (Genomics Core Director at Tufts University) attended.
Guglielmo Roma (Senior Investigator, Group Leader at Novartis) will be attending.
Hans-Rudolf Hotz (Bioinformatician) will be attending.
Justin Purackal (Commercial Manager, Life Sciences, Hanson Wade) will be attending.
Adam Irvine (Research and Innovation Services at University of Southampton) will be attending.
Thomas Sicheritz-Ponten (Professor in Metagenomics at the Technical University of Denmark) will be attending.
Mike Burden (Senior Conference Producer at Oxford Global) will be attending.
Boris Rugel (Biochemistry M.Sc. | Project manager and logistics coordinator at Hrast Ltd. | CEO at SeqComplete LLC.) will be attending.
Coralie Vacher (Senior Sales & Business Development Consultant - Nordic Countries & London Key Account Manager) will be attending.
Gurdip Kalley (Business Development Manager at S3) will be attending.
Show More...
Become a LinkedIn member. It's free!
Network with others attending this event
Attendees by company
Oxford Global
4
Novartis
1
Friedrich Miescher Institute
1
Hansonwade
1
University of Southampton
1